APP and Alzheimer disease: In AD, miR-124 mimic was used to regulate BACE1 and alleviate cell death induced by Aβ neurotoxicity [289], and reduce APP gene expression [59], while the use of a miR-124 antagomir resulted in the attenuation of tau phosphorylation and increased PTPN1 levels [62].